Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)

BACKGROUND: The treatment of patients with haematological malignancies by means of haematopoietic stem cell transplantation (HSCT) is often accompanied by life threatening infections. With emerging antimicrobial resistance there is an increased need for new agents, with a beneficial safety profile....

Descripción completa

Detalles Bibliográficos
Autores principales: van der Velden, Walter JFM, van Iersel, Thijs MP, Blijlevens, Nicole MA, Donnelly, J Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746231/
https://www.ncbi.nlm.nih.gov/pubmed/19735580
http://dx.doi.org/10.1186/1741-7015-7-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746231/
https://www.ncbi.nlm.nih.gov/pubmed/19735580
http://dx.doi.org/10.1186/1741-7015-7-44

Ejemplares similares